His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Introduction Over 100 000 service users are admitted to acute mental health wards annually, many involuntarily. Wards are under incredible pressure due to high bed occupancy rates and staff shortages.

Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to ...

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is ...

More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted ...

Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

This is the classic therapeutic approach where a counsellor sits and talks to their client. The most common technique a ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...